Lotte Biologics will move to secure global clients ahead of the completion of the first plant at the Songdo Bio Campus in August.
Lotte Biologics said on the 4th that it will participate in the world's largest bio industry event, the 2026 BIO International Convention (BioUSA), to be held in San Diego this month. The company has taken part in the event for five consecutive years since 2022.
At this event, Lotte Biologics will set up a standalone exhibition booth to discuss business collaboration plans with global pharmaceutical and bio corporations. The booth will feature a dedicated space for client meetings and a presentation program introducing the company's vision and manufacturing capabilities.
In particular, this year it will unveil for the first time the first plant at the Songdo Bio Campus, slated for completion in August. It plans to showcase photo and video content of the plant's internal production processes, floor-by-floor layout, and key equipment to highlight its large-scale commercial manufacturing capacity and customized manufacturing competitiveness.
During the event, it will also hold three in-booth presentations. On the first day, it will introduce collaboration strategies in development and manufacturing with the U.S. biotech corporation Asimov. On the second day, it will present a scale-up strategy using computational fluid dynamics (CFD), and on the third day, it will outline operational innovation through the digitalization of manufacturing processes.
It will also run an interactive program introducing its capabilities in the Antibody-Drug Conjugate (ADC) field. ADC is one of the most closely watched next-generation anticancer technologies in the global pharmaceutical industry.
Lotte Biologics' strategy is to expand its global CDMO business by leveraging a "dual-site" production system through the consolidation of the Syracuse Bio Campus in the United States and the Songdo Bio Campus.
A company official said, "It is an important opportunity to introduce our manufacturing capabilities to potential global clients ahead of the completion of the first plant at the Songdo Bio Campus," adding, "Based on a dual-site operating system linking Syracuse and Songdo, we will strengthen our global CDMO competitiveness."